‘Mornings on the Seine’ Painting by Claude Monet Could Fetch Nearly $23 Million

Christie’s will sell a painting from Claude Monet’s Matinées sur la Seine series at its evening sale of 20th- and 21st-century art on March 7 in London for an estimated price of up to £18 million (US$22.7 million).

Matinée sur la Seine, temps net (Mornings on the Seine, clear weather) , 1897, was consigned by an unnamed collector who bought it in May 1978 at a Sotheby’s auction in New York for US$330,000, according to Christie’s. The painting is among early examples of Monet’s practice of serialising specific scenes, “a technique that would ultimately transform his art,” Christie’s said in a news release.

In this example, Monet painted the river Seine during summer mornings in 1896 and 1897. “Tracing the sun as it passes over the scene, from the first rays of light at dawn, to the full brilliance of the sun at mid-morning, this extraordinary sequence of works was conceived as a connected, interrelated sequence of canvases,” Christie’s said.

A viewer can see the sun rising across the canvases when they are exhibited as a group, the auction house said. It was after Monet painted the Creuse valley in central France at different times of day in 1889 that he returned to the idea of serialization. A painting from the Creuse series, Prairie fleurie à Giverny , 1890, also will be offered during the March 7 evening sale. Christie’s has not placed a value on the work yet, which is being consigned from a Japanese collection.

Another example from the Seine series, also painted in 1897, sold at Christie’s in November 2017 from the collection of Nancy Lee and Perry R. Bass. Titled simply Matinée sur la Seine , the painting sold for nearly US$23.4 million. Matinée sur la Seine, temps net has not been seen publicly since 1990, when it toured in an exhibition titled “Monet in the ‘90s: The Series Paintings,” which opened at the Museum of Fine Arts in Boston before traveling to the Art Institute in Chicago, and the Royal Academy of Arts in London.

The painting will be on view in New York from Friday through Wednesday, before being shown in Hong Kong from Feb. 21-23 and then in London, March 1-7.

President Donald Trump’s imposition of tariffs on trading partners have moved analysts to reduce forecasts for U.S. companies. Many stocks look vulnerable to declines, while some seem relatively immune.

Since the start of the year, analysts’ expectations for aggregate first-quarter sales of S&P 500 component companies have dropped about 0.4%, according to FactSet. The hundreds of billions of dollars worth of imports from China, Mexico, and Canada the Trump administration is placing tariffs on, including metals and basic materials for retail and food sellers, will raise costs for U.S. companies. That will force them to lift prices, reducing the number of goods and services they’ll sell to consumers and businesses.

This outlook has pressured first-quarter earnings estimates by 3.8%. Companies will cut back on marketing and perhaps labour, but many have substantial fixed expenses that can’t easily be reduced, such as depreciation and interest to lenders. Profit margins will drop in the face of lower revenue, thus weighing on profit estimates. The estimates dropped mildly in January, and then picked up steam in February, just after the initial tariff announcements.

“We are starting to see the first instances of analysts cutting numbers on tariff impacts,” writes Citi strategist Scott Chronert.

The reductions aren’t concentrated in one sector; they’re widespread, a concrete indication that the downward revisions are partly related to tariffs, which affect many sectors. The percentage of all analyst earnings-estimate revisions in March for S&P 500 companies that have been downward this year has been 60.1%, according to Citi, worse than the historical average of 53.5% for March.

The consumer-discretionary sector has seen just over 62% of March revisions to be lower, almost 10 percentage points worse than the historical average. The aggregate first-quarter earnings expectation for all consumer-discretionary companies in the S&P 500 has dropped 11% since the start of the year.

That could hurt the stocks going forward, even though the Consumer Discretionary Select Sector SPDR exchange-traded fund has already dropped 11% for the year. The declines have been led by Tesla and Amazon.com , which account for trillions of dollars of market value and comprise a large portion of the fund. The average name in the fund is down about 4% this year, so there could easily be more downside.

That’s especially true because another slew of downward earnings revisions look likely. Analysts have barely changed their full-year 2025 sales projections for the consumer-discretionary sector, and have lowered full-year earnings by only 2%, even though they’ve more dramatically reduced first-quarter forecasts. The current expectation calls for a sharp increase in quarterly sales and earnings from the first quarter through the rest of the year, but that’s unrealistic, assuming tariffs remain in place for the rest of the year.

“The relative estimate achievability of the consumer discretionary earnings are below average,” Trivariate Research’s Adam Parker wrote in a report.

That makes these stocks look still too expensive—and vulnerable to declines. The consumer-discretionary ETF trades at 21.2 times expected earnings for this year, but if those expectations tumble as much as they have for the first quarter, then the fund’s current price/earnings multiple looks closer to 25 times. That’s too high, given that it’s where the multiple was before markets began reflecting ongoing risk to earnings from tariffs and any continued economic consequences. So, another drop in earnings estimates would drag these consumer stocks down even further.

Industrials are in a similar position. Many of them make equipment and machines that would become more costly to import. The sector has seen about two thirds of March earnings revisions move downward, about 13 percentage points worse that the historical average. Analysts have lowered first-quarter-earnings estimates by 6%, but only 3% for the full year, suggesting that more tariff-related downward revisions are likely for the rest of the year.

That would weigh on the stocks. The Industrial Select Sector SPDR ETF is about flat for the year but would look more expensive than it is today if earnings estimates drop more. The stocks face a high probability of downside from here.

The stocks to own are the “defensive” ones, those that are unlikely to see much tariff-related earnings impact, namely healthcare. Demand for drugs and insurance is much sturdier versus less essential goods and services when consumers have less money to spend. The Health Care Select Sector SPDR ETF has produced a 6% gain this year.

That’s supported by earnings trends that are just fine. First-quarter earnings estimates have even ticked slightly higher this year. These stocks should remain relatively strong as long as analysts continue to forecast stable, albeit mild, sales and earnings growth for the coming few years.

“This leads us to recommend healthcare and disfavour consumer discretionary,” Parker writes.